Covington, Cooley Lead Drugmaker Odyssey's $279M IPO
By Jade Martinez-Pogue · May 8, 2026, 5:57 PM EDT
Venture-backed biotechnology firm Odyssey Therapeutics began trading publicly Friday after raising $279 million in its initial public offering, making it the latest biotech to hit the public markets over the last...
To view the full article, register now.